An online programme to reduce depression in patients with multiple sclerosis: a randomised controlled trial

Anja Fischer1, Johanna Schröder2, Eik Vettorazzi3

  • 1Institute of Neuroimmunology and Multiple Sclerosis (INIMS), Center for Molecular Neurobiology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

The Lancet. Psychiatry
|September 12, 2015
PubMed
Summary

An internet-based cognitive behavioral therapy program, Deprexis, effectively reduced depressive symptoms in multiple sclerosis patients. This online intervention offers a viable treatment option for managing depression in this population.

Related Concept Videos